Annona Muricata Hypoglycemic Effect
Annona Muricata Hypoglycemic Effect
Annona Muricata Hypoglycemic Effect
Abstracted by:
African Index Medicus (WHO), CAB Abstracts, Index Copernicus, Global Health Abstracts, Asian Science Index, Index
Veterinarius, Bioline International , African Journals online
African Journal of Biomedical Research 2006 (Vol. 9) / Adedapo, Arinola, Ige, Adedapo and Salimonu
(Lopez Abraham, 1979). Much of the recent oxidase and xanthine oxidase (Guzik et al; 2002;
research on A. muricata has been on a novel set of Etoh et al; 2003). (iii) mitochondria respiratory
phytochemicals (Annonaceous acetogenins) that are chain, during oxidative phosphorylation process,
found in the leaves, seeds and stem which are electrons are transferred from electron carriers
cytotoxic against various cancer cells (Chang, 2001; NADH and FADH2 to oxygen, thus generating ATP
Chang, 2003; Liaw, 2002). in the process (Green et al; 2004).
Streptozotocin (STZ), an antibiotic produced by Annona muricata has a long history of use in
Streptomyces achromogenes, possesses pancreatic β- herbal medicine in the tropical areas in South and
cell cytotoxic effect (Weiss, 1982). Streptozotocin North America including the Amazon and West
has been widely used for inducing diabetes mellitus Africa. All parts of the tree are claimed to be used in
in a variety of animals. STZ causes degeneration and natural medicine, in view of this, the present study
necrosis of pancreatic β-cells (Uchigata et al; 1982; was designed to evaluate the hypoglycemic,
Merzouk et al; 2000). Although the mechanism of morphological changes of pancreatic β-cells and
the β-cell cytotoxic action of STZ is not fully antioxidant effects of A. muricata leaf aqueous
understood, experimental evidence has demonstrated extract in experimental models of diabetes mellitus
that some of its deleterious effects are attributable to in rats.
induction of metabolic processes, which lead on to
an increase in the generation of reactive oxygen MATERIALS AND METHODS
species (ROS) (Chen et al; 1990). Apart from
production of ROS, STZ also inhibits free radical Animal care and monitoring: Healthy, male and
scavenger-enzymes (Kröncke et al; 1995). The female, Wistar rats (Rattus norvegicus) weighing
superoxide radical has been implicated in lipid 250–300 g (averaging 12 weeks old) and normal
peroxidation, DNA damage, and sulfhydryl Mice (Mus domesticus) were used in this study.
oxidation (Tiedge et al; 1997; Matkovics et al; They were housed under standard laboratory
1998). conditions of light, temperature (21±2oC) and
Oxidative stress is the excess formation and/or relative humidity (55±5%). The animals were given
insufficient removal of highly reactive molecules standard rat pellets and tap water ad libitum. The
such as reactive oxygen species (ROS) and reactive rats were randomly divided into three experimental
nitrogen species (RNS) (Turko et al; 2001; Maritim groups: A (control), B (STZ-treated), C (STZ + A.
et al; 2003). ROS include free radicals such as muricata-treated). The control group animals (A)
superoxide (O2-), hydroxyl (OH-), peroxyl RO2), consisted of ten rats, while groups B and C consisted
hydroperoxyl (HRO2-) as well as nonradical species of forty rats. The mice were used for acute toxicity
such as hydrogen peroxide (H2O2), and testing of the crude plant extract, while the rats were
hydrochlorous acid (HOCl) (Evans et al; 2003). used for hypoglycemic and morphological
RNS include free radicals like nitric oxide (NO) and evaluations of the plant’s extract. Maintenance and
nitrogen dioxide (NO2-), as well as nonradicals such treatment of animals were in accordance with the
as peroxynitrite (ONOO-), nitrous oxide (HNO2) and principles of the “Guide for care and use of
alkyl peroxynitrates (RONOO) (Liu et al; 2002). Of laboratory animals in research and teaching”
these reactive molecules, O2-, NO and ONOO- are prepared by the National Institutes of Health (NIH)
the most widely studied species and play important publication 86-23 revised in 1985.
roles in the diabetic cardiovascular complications.
Oxidative stress in diabetes, sources from (i) Plant material : Fresh leaves of Annona muricata
nonenzymatic source resulting from biochemical (Linn.) (family, Annonaceae) (locally known as
oxidation of glucose, glucose reacts with protein in “Soursop in English, and “Abo” in Yoruba language
nonenzymatic manner leading to the development of of Western Nigeria) were collected in Ibadan,
advanced glycation end product (AGE) (Taniyama Nigeria between April and May 2006. The leaves
and Griendling, 2003). (ii) enzymatic sources which were identified, by the Taxonomist/Curator of the
includes nitric oxide synthetase (NOS), NAD(P)H Department of Botany, Obafemi Awolowo
University, Ile-Ife, Nigeria, as those of A. muricata diabetic ‘test’ rats. 1, 2, 3, 4 and 8 h following oral
Linn. (family, Annonaceae). Voucher specimen of administrations of the test compound to the animals,
the plant has been deposited in the Herbarium of the blood glucose concentrations (Gt) were again
University’s Botany Department. determined and recorded. In each case and for each
dose, the rats were restrained in a cage, and blood
Preparation of Annona muricata leaf aqueous samples (0.02 ml) were collected from the tail vein
extract: A. muricata fresh leaves were air-dried at of each rat for blood glucose analysis. Percentage
room temperature. One kilogram of the air-dried glycemic variation was calculated as a function of
leaves of the plant was milled into fine powder in a time (t) by applying the formula:
Waring blender, department of Pharmacognosy, % glycemic change = Go – Gt x 100/Go
Obafemi Awolowo University, Ile-Ife, Nigeria. The [where Go and Gt represent glycemic values before
powdered leaf was macerated in distilled water and (i.e., 0-time or 0-h glycemic values), and glycemic
extracted twice, on each occasion with 2.5 1itre of values at 1, 2, 3, 4 and 8 hours after, oral
distilled water at room temperature for 48 h. The administrations of ‘test’ compound respectively].
combined aqueous extract solubles were
concentrated to dryness under reduced pressure at Induction of experimental diabetes: Diabetes
60oC±1oC in a rotary evaporator. The resulting mellitus was induced (in groups B and C ‘test’ rats)
aqueous extract was freeze-dried, finally giving by single intraperitoneal injection of STZ (75
26.23 g (i.e., 2.62% yields) of a light green, powdery mg/kg), freshly dissolved in 0.1mol/l citrate buffer
crude aqueous leaf extract of A. muricata (AME). (Rossini et al; 1978). Control rats were injected with
Aliquot portions of the crude plant extract residue only citrate buffer solution (pH 6.3)
were weighed and dissolved in distilled water for intraperitoneally. The ‘test’ animals in groups B and
use on each day of our experiments. C became diabetic within 48 hours after STZ
administration. Diabetic state was confirmed by
Acute toxicity testing: The median lethal dose measuring basal blood glucose concentration 48
(LD50) of A. muricata leaf aqueous extract (AME) hours after STZ injection. Diabetes was allowed to
was determined in the rat using a modified method develop and stabilize in these STZ-treated rats over
of Lorke, (1983). Mice fasted for 16 h were a period of 3-5 days. All animals in groups A, B and
randomly divided into groups of eight mice each. C were kept and maintained under laboratory
Graded doses of AME (50, 100, 200, 400, 800, 1600 conditions of temperature, humidity, 12-h day – 12-
and 3200 mg/kg) were separately administered h night cycle; and were allowed free access to food
intraperitoneally (i.p.) to the mice in each of the test (standard pellet diet) and water ad libitum. Before
groups. Each of the mice in the control group was the commencement of our experiments, both the
treated only with distilled water (3 ml/kg, i.p.). The control normal (normoglycemic) and STZ-treated,
mice in both the test and control groups were then diabetic (hyperglycemic) test rats were fasted for 16-
allowed free access to food and water, and observed h, but still allowed free access to water throughout.
over a period of 48 h for signs of acute toxicity. The At the end of the 16-h fasting period – taken as 0
number of deaths (caused by the extract) within this time (i.e., 0 h) – blood glucose levels (initial
period of time was noted and recorded. Log dose- glycemia, G0) of the fasted normal and STZ-treated,
response plots were constructed for the plant’s diabetic rats were determined and recorded. Fasted
extract, from which the LD50 of the leaf aqueous STZ-treated rats with blood glucose concentration
extract was determined. ≥18 mmol/L were considered to be diabetic, and
used in this study. The test compound [i.e., Annona
Evaluations of hypoglycemic activity of A. muricata leaf aqueous extract (AME, 100 mg/kg
muricata leaf aqueous extract (AME): The test p.o.)] was administered orally (by gastric intubation)
compound (i.e., A. muricata leaf aqueous extract to the group C fasted diabetic rats. The
(AME, 50-400 mg/kg) were administered orally to administration of plant’s aqueous extract was
the groups of fasted normal (control) and fasted commenced as from the 5th day post STZ injections.
sodium pyrophosphate buffer (0.052 mM, pH 7.0), standard. Results are expressed as nmoles
0.1 ml of phenazine methosulphate (PMS) (186 TBARS/mg tissue.
μM), 0.3 ml of nitro blue tetrazolium (NBT) (300
μM). 0.2 ml of the supernatant obtained after Nitric Oxide (NO)
centrifugation (1500 x g, 10 min followed by 10,000 Serum nitrite/nitrate levels were determined by
x g, 15 min) of 5% pancreatic homogenate was converting the nitrate to nitrite, using enzyme nitrate
added to reaction mixture. Enzyme reaction was reductase followed by addition of Griess reagent to
initiated by adding 0.2 ml of NADH (780 μM) and colorimetrically quantify the nitrite concentration
stopped precisely after 1 min by adding 1 ml of (Green et al; 1982). The serum was diluted 1:5 in
glacial acetic acid. Amount of chromogen formed PSB before a 25-µl aliquot was added to a mixture
was measured by recording color intensity at 560 of 25 µl nitrate reductase (1.5 U/ml) and 25 µl of
nm. Results are expressed as units/mg protein. NADPH (0.134 mg/ml), both prepared in 40 mM
Tris, pH 7.6. The samples were thereafter incubated
Glutathione Peroxidase Activity (GSH-Px): at room temperature for 3 hours. Following this
Glutathione peroxidase (GSH-Px) activity was period, 100 µl of Griess reagent (1:1 mixture of 1%
measured by NADPH oxidation, using a coupled sulphanilamide in 5% phosphoric acid and 0.1%
reaction system consisting of glutathione, naphyly-ethylenediamine) was added and incubated
glutathione reductase, and cumene hydroperoxide for a further 10 min at room temperature; the
(Tappel, 1978). 100 µL of enzyme sample was absorbency of the samples was measured at 540 nm
incubated for five minutes with 1.55 ml stock with a 650 nm reference. The concentration of
solution (prepared in 50 mM Tris buffer, pH 7.6 nitrite/nitrate was determined from a standard curve
with 0.1 mM EDTA) containing 0.25 mM GSH, of sodium nitrate and calculated as µM
0.12 mM NADPH and 1 unit glutathione reductase. nitrite/nitrate.
The reaction was initiated by adding 50 µL of
cumene hydroperoxide (1 mg/ml), and the rate of Immunohistochemistry
disappearance of NADPH with time was determined The animals were sacrificed by cervical dislocation,
by monitoring absorbance at 340 nm. One unit of some at the end of the 16 hours fasting period, and
enzyme activity is defined as the amount of enzyme others on various days following STZ
that transforms 1 µmol of NADPH to NADP per administration. Pancreatic tissues were excised and
minute. Results are expressed as units/mg protein. weighed after the fat and lymphnodes had been
removed. The splenic parts of the pancreas of each
Lipid Peroxidation contents (LPO): The product rat were fixed in aqueous Bouin’s solution, and
of the reaction between malondialdehyde (MDA) embedded in paraffin. Each pancreatic block was
and thiobarbituric acid reactive substances (TBARS) serially sectioned (5 μ) throughout its length to
were measured by a modified method of Ohkawa et avoid any bias due to changes in islet distribution or
al., (1979). For each sample to be assayed, four cell composition, and thereafter mounted on slides.
tubes were set up containing 100, 150, 200 and 250 For each pancreas, 10 sections were randomly
µL of tissue homogenate, 100 µL of 8.1% SDS, 750 chosen at a fixed interval through the block (every
µL of 20% acetic acid, and 750 µL of 0.8% aqueous 30th section), a procedure that has been shown to
solution of TBA. The volume was made up to 4 ml ensure that selected sections are representative of the
with distilled water, mixed thoroughly and heated at whole pancreas (Mossavat et al; 1997). Sections
95oC for 60 minutes. After cooling, 4 ml of n- were immunostained for insulin, using a peroxidase
butanol was added to each tube, the contents mixed indirect labeling technique. The sections were
thoroughly, and then centrifuged at 3000 rpm for 10 incubated for 1 h with guinea-pig anti-insulin serum
minutes. The absorption of the clear upper (n- (final dilution 1:1,000, Ref. 64-104-1; Aurora, OH).
butanol) layer was read at 532 nm. 1, 1, 3, 3 Thereafter, sections were incubated for 45 min with
tetraethoxy propane (97%) was used as the external peroxidase-conjugated rabbit anti-guinea pig IgG
(final dilution 1:20; Dako, Carpinteria, CA). The
Table 1.
Various parameters recorded in control, STZ-treated and STZ + AME-treated diabetic rats just before and after treatment.
Values presented represent the means (± SEM) of 10 observations.
Parameters Control STZ-treated STZ + AME-treated
Body weight (g) Initial 242±12 239±14a 241±17a
Final 249±11 197±17b 244±13a
Pancreatic weight (g) Initial 0.31±1.2 0.29±1.5 0.29±1.4
Final 0.31±1.9 0.22±1.4 0.30±1.5
Blood glucose (mmol/l) Initial 4.1±0.1 19.2±0.5c 4.1±0.2a
c
Final 4.0±0.2 21.5±0.7 4.7±0.1a
d
Serum insulin (μU/ml) Initial 13.9±1.3 9.3±1.3 10.6±0.3a
d
Final 13.7±1.1 5.3±1.5 12.2±0.1a
Values are expressed as means (±SEM) of 10 rats. Insignificant difference (p>0.05) between all groups. b,c,d Significant
a
Table 2.
Changes in blood glucose concentrations and serum/pancreatic insulin contents in control, STZ-treated and
STZ + AME-treated diabetic rats.
Control Treated
Days 0 10 20 30 40 50 60
also significantly increased (p<0.05) the reduced improvement in the islet of Langerhans with distinct
antioxidant enzyme activities. Also, AME proved cellularity changes, majority of the cells showed
significantly better in restoring the altered activity of viable islet of Langerhans, with increase in
antioxidant enzymes like CAT, GSH, SOD, GSG-Px granulation (Plate 1a).
and MDA, NO and insulin towards their normal
values in the pancreas. Immunohistochemical findings
Immunohistochemistry staining of the pancreatic
Histopathological findings tissues before STZ injection showed the presence of
Histologically, in diabetic rats with no treatment, the a strong islet insulin immunoreactivity at a level of
most consistent findings in the sections of pancreatic 0.59 islet/mm2 of total pancreatic tissue. This was
tissues were breakdown of micro-anatomical limited to cytoplasmic staining of individual β-cells
features such as extensive β-cell degranulation, (Fig. 4A). The majority of islets from AME-treated
decreased cellular density, and an indistinct boarder pancreases stained positive for insulin suggesting
between the endocrine and exocrine regions. Also that the architecture of AME-treated rats was normal
there was a diffused degenerative and necrotic (Fig. 4C). In contrast, islet cells from diabetic rats
changes, and shrunken in the islet of Langerhans were architecturally distorted, containing
(Plate 1b). The nucleus of necrotic cells showed significantly fewer insulin-positive cells (Fig. 4B).
either pyknosis of marginal hyperchromasia, and the Quantitative image analysis was used to assess the
cytoplasm were filled by hydropic changes (Plate proportion of insulin positive cells per islet in
1b). The α-cells, exocrine pancreatic acinar control, STZ-treated and STZ + AME-treated
epithelium, ductal and connective tissues appeared pancreatic sections. The percentage of islets stained
normal (Plate 1a and 1b). Identifiable pancreatic for insulin were 76.35 ± 19%, 42.26 ± 3.2% and
islets of diabetic rats as from day 10 were of low 68.56 ± 24% (p < 0.05) respectively (Fig. 4A, 4B
cellularity, although there was no evidence of and 4C). Together, these findings further support
inflammatory cell infiltration (Plate 1b). In diabetic that AME protected islets from destruction.
rats treated with A muricata, there was a remarkable
A B C
Plate 1
Aldehyde fuchsin trichrome staining of the pancreatic tissues. Arrows show β-cells with purple colour, while arrowheads
show α-cells in orange colour. (C) Control group: showing normal cells in the islet of Langerhans and showing distinct
granules filling the entire islet of Langerhans that are strongly stained purple, α-cells are seen mostly at the periphery. (B)
Diabetic untreated group: shrunken islet of Langerhans displaying degenerative and necrotic changes, nuclear shrinkage
and pyknosis were evident with cytoplasmic vesiculation in the centre of the islet of Langerhans, decreased cellular
density. (A) STZ+AME-treated: still retained substantial amount of β-cells with moderate staining granules, and distinct
endocrine and exocrine boarder, α-cell still highly populated within the islet of Langerhans X 160.
A B C
Plate 2
Immunohistochemistry staining of the pancreatic tissues, represented by dark granules. (A) Control group: showing
normal β-cells in the islet of Langerhans that are strong staining with the anti-insulin antibody. Immunoperoxidase,
haematoxylin counterstain. (B) Diabetic untreated group: showing shrunking islet with weak immunoreactive β-cells in
the islet of Langerhans. Immunoperoxidase, haematoxylin counterstain. (C) STZ-AME treated: still retained substantial
amount of β-cells with remarkable anti-insulin antibody staining granules. Immunoperoxidase heamatoxylin
counterstain X 160.
Of interest is the stability of pancreatic insulin Generally, the fruit and fruit juice are taken for
content of the AME-treated rats (15.6±2.1 μU/mg), worms and parasites, to cool fevers, to increase
in contrast with the STZ-treated rats, pancreatic mother’s milk after childbirth, and as an astringent
insulin contents were ~65-fold higher (Table 2). for diarrhea and dysentery. The crushed seeds are
This stability in pancreatic insulin values was also used against internal and external parasites, head lice
observed to reflect in the immunohistochemistry and worms. The bark, leaves, and roots are
staining (Fig. 4C). Immunohistochemistry staining considered sedatives, antispasmodic, hypoglycemic,
intensity was an evidence of protective effects/or hypotensive, diuretics, neuralgia (Hasrat et al;
regenerative processes leading to increase in β-cell 1997). Phytochemically, many active compounds
mass, regaining its normal immunostaining for and chemicals have been found in A. muricata, as
insulin and functional status up to the day of scientists have been studying its properties since the
normoglycemia. 1940s. The tree is rich in ellagic acid, tannins,
lactones, and isoquinoline alkaloids. The leaf, stem,
DISCUSSION bark and seeds also contain varying amounts of a
novel group of chemicals believed to be biologically
The aim of the present study was to demonstrate the active, called Annonaceous acetogenins (Tormo et
efficacy of Annona muricata in the reduction of al; 2003; Kojima, 2004), and this include:
blood glucose concentration as well as to determine annocatalin, annohexocin, annomonicin,
the recovery in altered biochemical variables, annomontacin, annomuricin, annomutacin,
indicative of oxidative stress and organ damage in annonacin to mention a few. Purdue researchers
STZ-treated rats. Ethnobotanically, all parts of A. reported that 14 different acetogenins tested thus far
muricata tree have been used medicinally in the demonstrate potent ATP-blocking properties and
tropics, including the bark, leaves, roots, fruit, and were more potent against multi-drug resistant
fruit seeds (Mors, 2000; Haddock, 1994). Different (MDR) cancer cells (Oberlies et al; 1995). A tumor
properties and uses are attributed to the different cell needs energy to grow and reproduce and by
parts of the A. muricata by the Traditional herbal inhibiting energy to the cell, it can no longer run its
medicine practitioners (Padma et al; 2001). pump and expel attacking agents (Yuan et al; 2003).
The increasing prevalence of diabetes is reaching However, subsequent discovery that insulin
epidemic proportion worldwide. Diabetes is a major administration was not necessary for the reduction of
threat to global public health that is rapidly glycosuria and indeed for the control of the disease
escalating (WHO, 2000). It is estimated that more raised ‘queries’ about the role of insulin. The later
than 170 million people are suffering from diabetes demonstration that diabetes had developed in
globally and this number is expected to double by persons whose serum insulin levels were not only
2030, and the greatest increase in prevalence is, adequate, but excessive, further confounded the
however, expected to occur in Asia and Africa, ideas and thinking of both clinicians and researchers
follow the trend of urbanization and lifestyle in the field of diabetes. Birth of the concept of
changes (WHO, 1999). Diabetes and its multiple insulin resistance then took place and provided an
complications are extremely burdensome on the answer to some of the questions. Nevertheless
health and economics of countries worldwide. In insulin production by the beta cells continued to
developing countries adherence to therapies is as attract attention and β-cell failure in type 2 diabetes
low as 20%, resulting in poor health outcomes at a is now being demonstrated (Knowler et al; 2002).
very high cost to society, governments and families What must be of further interest now, however, is
(Caro et al; 1987). If not successfully managed, concept of incorporation of scientifically proved
diabetes along with other chronic diseases will herbal medicine.
become the most expensive problem faced by the The three main classes of biological macromolecules
health care systems. Because of its associated that are susceptible to free radical attack under
morbidity and mortality, it is exerting a major diabetic condition are lipids, nucleic acids and
pressure on the healthcare system, and with a better proteins; the attacks affects the entire tissues in the
understanding of the pathophysiology, a new care body and suffer oxidative damage (Halliwell and
perspective and reform in the training of the health Gutteridge, 1989). Primary effect of lipid
workforce is essential. The new care perspective peroxidation is decreased membrane fluidity, which
advocates for the use of the Innovative Care for alters membrane properties and can significantly
Chronic Conditions framework which integrates disrupt membrane-bound proteins (Tappel, 1975).
prevention, control and treatment of the disease The oxidation of proteins includes oxidation of
across multiple levels of health care system sulfhydryl groups, reduction of disulfides, oxidative
particularly in low resources settings. In Africa, adduction of amino acid residues close to metal-
many plants have been reported to possess binding sites via metal-catalyzed oxidation,
antidiabetic or hypoglycemic activities (Ojewole, reactions with aldehydes, protein-protein cross-
2001; Iwu, 1993; Marles and Farnsworth, 1995). linking, and peptide fragmentation (Standman and
Indeed, hundreds of plants are now being used Oliver, 1991; Starke-Reed and Oliver, 1989).
traditionally for the management of both insulin- Oxidative damage to nucleic acids includes adducts
dependent (IDDM) and noninsulin-dependent of base and sugar groups, single- and double-strand
(NIDDM) diabetes mellitus. To date, however, only breaks in the backbone, and cross-links to other
a few of these plants have been subjected to molecules, this causes damage to all four bases and
scientific scrutiny either in laboratory animals or in thymine-tyrosine cross-link (Dizdaroglu, 1992;
human subjects (Ross, 1999). Halliwell and Dizdaroglu, 1992). In the present
Although diabetes has been recognized since study we used aqueous extracts, obtained from A.
antiquity, and treatments of various efficacy have muricata leaves and studied its effect on pancreatic
been known since the middle ages, the elucidation of β-cells. Our observations demonstrated that STZ-
the pathogenesis of diabetes occurred mainly in the induced oxidative stress and β-cell damage as
20th century (Nathan et al; 2005). The discovery of revealed by histological and immunohistochemical
the action and importance of insulin in the staining results. Depletion of endogenous
metabolism of glucose, not surprisingly, led to the antioxidants and generation of free radicals were
belief that lack of insulin was the critical factor in also noted which are in consonance with the findings
the development of the disease (Patlak, 2002). of Buttke and Sandstorm (1994). A. muricata caused
significant decrease in elevated blood glucose and an pancreatic tissues. Nevertheless, A. muricata
increase in serum insulin concentrations as well as exhibited antioxidant activity, and is able to
pancreatic insulin contents in STZ-treated diabetic diminish and/or prevent, pancreatic oxidative
rats. Histologically, A. muricata partly protected damage produced by STZ. An increased
pancreatic β-cell integrity. It saved the tissue from consumption of antioxidants in the diet of
the usual shrunken islets, denegation, degranulation, individuals is strongly recommended, so that when
hydropic and necrotic changes peculiar to STZ- an individual is subjected to greater oxidative stress,
induced pancreatic injuries. Immunohistochemistry he/she would have better antioxidant defense
staining was evident of significantly better characteristics, thus counteracting the effects of any
restoration of altered micro-anatomy of islet of pro-oxidant. However, further studies are needed
Langerhans of STZ-treated diabetic rats. We also before antioxidants can be used safely as food
analyzed the intracellular level and activities of additives and supplements.
GSH, SOD, CAT, GSH-Px, MDA, NO and insulin
contents and we found that STZ treatment caused Acknowledgements
significant increases in blood glucose concentration, The authors are grateful to Professor J.A.O. Ojewole for
MDA and NO generation, and decreased GSH, his expertise and useful advice in some of the procedures.
SOD, CAT, GSH-Px, activities as well as insulin We also thank Messrs Adeogun Oludele, Doherty O.
Wiston for their technical assistance in plants processing.
levels when compared with control rats. Decreases
Ms Kogie for her excellent technical assistance in tissue
in GSH, SOD, CAT and GSH-Px, and simultaneous processing.
increases in MDA and NO activities, reflect
susceptibility of pancreas to STZ’s significant
oxidative stress. Thus, this study has demonstrated REFERENCES
that STZ alters the activity of oxidant defenses in the
pancreas. This observation is in agreement with the Akah P. A., Okafor C. L. (1992): Blood sugar
studies reported by Henriksen (2002), Gul et al; lowering effect of Vernonia amygdalina (Del) in an
(2002) and Derouich and Boutayeb (2002). experimental rabbit model. Phytother Res 6, 171-173.
The data obtained in the present study do not allow Alldrick A. J., et al. (1986): Effects of plant-derived
definite conclusion to be drawn on the mechanisms flavonoids and polyphenolic acids on the activity of
of action of AME in the experimental animal mutagens from cooked food. Mutat Res 163(3), 225-
paradigms used. However, a number of investigators 232.
have shown that tannins and other polyphenolic Ames B. N., Shigenaga M. K., Hagen T. M. (1993):
compounds (e.g., coumarins), flavonoids, Oxidants, antioxidants, and the degenerative diseases
triterpenoids, saponins, and a host of other plant of aging. Proc Natl Acad Sci (USA) 90, 7915-7922
secondary metabolites possess hypoglycemic, Ayensu E. S. (1981): Medicinal plants of the West
hypotensive, anti-inflammatory, and other Indies. Algonac, Michigan: Reference Publications.
pharmacological properties in various experimental Bailey C. J., Day C. (1989): Traditional plant
animal models (Ojewole, 2004; 2005; Akah and medicines as treatment for diabetes. Diabetes Care; 12,
Okafor, 1992). A. muricata is known to contain 553-564.
ellagic acid, tannis, flavonoids, polyphenolic Barch D. H., et al. (1994): Ellagic Acid Induces
compounds, β-sistosterol, and catechins (Ames et al; NAD(P)H: Quinone reductase through activation of
1993; Decker, 1997; Barch et al; 1994; Alldrick et the antioxidant regulatory element of the rat
al; 1986); therefore it is not unreasonable to NAD(P)H: Quinone Reductase Gene. Carcinogenesis
15, 2065-2068.
speculate that some of these chemical compounds
Buttke T. M., Sandstorm P. A. (1994): Oxidative
especially the coumarins and flavonoids are
stress as a mediator of apoptosis; Immunol. Today 15,
probably responsible for recovery in the altered
7-10.
biochemical variables and pancreatic tissues. Caro J. F., Sinatia M. K., Raju S. M et al. (1987):
Based on our findings, we conclude that STZ Insulin receptor kinase in human skeletal muscle from
administration is associated with oxidative stress in
obese subjects with and without non-insulin dependent Green K., Brand M. D., Murphy M. P. (2004):
diabetes. J Clin Invest 79, 1330-1337. Prevention of mitochondrial oxidative damage as a
Chang R. F. (2001): “Novel cytotoxic annonaceous therapeutic strategy in diabetes. Diabetes. 53, S110-
acetogenins from Annona muricata.” J. Nat. Prod. 118.
64(7), 925-931. Haddock R. L. (1994): “Some medicinal plants of
Chang R. F. et al. (2003): “New adjacent bis- Guam including English and Guamanian common
tetrahydrofuran annonaceous acetogenins from names.” Report Regional Tech Mtg Med Plants,
Annona muricata.” Planta Med. 69(3), 241-246. Papeete, Tahiti, Nov, 1973; South Pacific Commision,
Chen Y. T., Zheng R. L., Jia Z. J., Ju Y. (1990). Noumea, New Caledonia, pp. 79.
Flavonoids as superoxide scavengers and antioxidants. Halliwell B. H., Gutteridge J. M. C. (1989): Free
Free Radic. Biol. Med., 9, 19–20. radicals in Biology and Medicine. Free Radical Res.
Decker D. A. (1997): Phenolics: proxidant or Commum. 16, 75-87.
antioxidants. Nutr Rev 55, 396-398. Halliwell B. H., Dizdaroglu M. (1992): The
de Feo V. (1992): Medicinal and magical plants in the measurement of oxidative damage to DNA by HPLC
northern Peruvian Andes. Fitoterapia 63, 417-440. and GC/MS techniques. Free Radicals Res. Commun
Derouich M., Boutayeb A. (2002). The effect of 16, 75-87.
physical exercise on the dynamics of glucose and Hasrat J. A., et al. (1997): Screening of medicinal
insulin. J. Biochem., 35, 911–917. plants from Suriname for 5-HT 1A ligands: Bioactive
Dizdaroglu M. (1992): Measurement of radiation- isoquinoline alkaloids from the fruit of Annona
induced damage to DNA at the molecular level. Int. J. muricata. Phytomedicine. 4(20), 133-140.
Radiat. Biol. 61, 175-183. Heinrich M. (1992): Parasitological and
Etoh T., Inoguchi T., Kakimoto M., Sonoda N., Microbiological Evaluation of Mixe Indian Medicinal
Kobayashi K., Kuroda J., Sumimoto H., Nawata H. Plants (Mexico) J. Ethnopharmacol 361, 81-85.
(2003): Increased _expression of NAD(P)H Henriksen E. J. (2002). Invited review: Effects of
oxidase subunits, NOX4 and p22phox, in the kidney of acute exercise and exercise training on insulin
streptozotocin-induced diabetic rats and its resistance. J. Appl. Physiol., 93, 788–796.
reversibility by interventive insulin treatment. Henry, J. D. (1984). Clinical diagnosis and
Diabetologia. 46, 1428-1437. management by laboratory methods. 17th ED., p.1433.
Evans J. L., Goldfine I. D., Maddux B. A., Grodsky Hissin P. J., Hilf R. (1973): A fluorometric method
G. M. (2003): Are oxidative stress-activated signaling for the determination of oxidized and reduced
pathways mediators of insulin resistance and {beta}- glutathione in tissue, Anal. Biochem. 74, 214-226.
cell dysfunction? Diabetes. 52, 1-8. Holdsworth D. K. (1990): “Traditional Medicinal
Gul M., Laaksonen D. E., Atalay M., Vider L., Plants of Rarotonga, Cook Islands.” Part I. Int. J.
Hannien O. (2002). Effects of endurance training on Crude Drug Res. 28(3), 209-218.
tissue glutathione homoestasis and lipid peroxidation Iwu M. M. (1993): Catalog of major African
in streptozotocin-induced diabetic rats. Scand. J. Med. medicinal plants. In: Handbook of African Medicinal
Sci. Sports, 12, 163–170. Plants. Iwu, M.M., (Ed.). CRC Press: Boca Raton, Fl,
Gulliford M. C. (1994): Health and health care in the 9-101.
English-speaking Caribbean. J Public Health Med 16, Johansson L. H., Borg L. A. (1988). A
263-269. spectrophotometric method for determination of
Guzik T. J., Mussa S., Gastaldi D., Sadowski J., catalase activity in small tissue samples. Anal
Ratnatunga C., Pillai R., Channon K. M. (2002): Biochem., 174, 331–336.
Mechanisms of increased vascular superoxide Kakkar P., Das B., Viswanathan P. N. (1984): A
production in human diabetes mellitus: role of modified spectrophotometric assay of superoxide
NAD(P)H oxidase and endothelial nitric oxide dismutase, Ind. J. Biochem. Biophys 21, 130-132.
synthetase. Circulation. 105, 1656-1662. Keen R. W., Deacon A. C., Delves H. T., Moreton J.
Green L. C., Wagner D. A., Glogowski J., Skipper A., Frost P. G. (1994): Indian herbal remedies for
P. L., Wishnok J. S., Tannenbaum S. R. (1982). diabetes as a cause of lead poisoning. Postgrad Med J
Analysis of nitrate, nitrite and [15N] nitrate in 70, 113-114.
biological fluids. Anal. Biochem., 126, 131–138.
Kekow J., Ulrichs K., Muller-Ruchholtz W., Gross lipase activities in macrosomic offspring of rats with
W. L. (1988). Measurement of rat’s insulin: enzyme- streptozotocin-induced diabetes. Clin. Sci., 98, 21–30.
linked immunosorbent assay with increased sensitivity, Misas C. A. J. (1979): Contribution to the Biological
high accuracy, and greater practicability than Evaluation of Cuban Plants.IV. Rev Cub Med Trop
established radioimmunoassay. Diabetes, 37, 321P. 311, 29-35.
Knowler W., Barrett-Connor E., Fowler S., Mor S. B., et al. (2000): Medicinal plants of Brazil.
Hamman R., Lachin J., Walker E., Nathan D. Algonac, Michigan, Reference Publications, Inc.
(2002): “Reduction in the incidence of type 2 diabetes Morgan M., Watkins C. J. (1988): Managing
with lifestyle intervention or metformin.” N Engl J hypertention: beliefs and responses to medication
Med 346 (6), 393-403. among cultural groups. Sociol Health Illn, 10, 561-
Kojima N. (2004): “Systemic synthesis of antitumor 578.
Annonaceous acetogenins” Yakugaku Zasshi. 124(10), Morgan M. (1995): The significance of ethnicity for
673-681. health promotion: patients’ use of anti-hypertensive
Kröncke K. D., Fehsel K., Sommer A., Rodriguez drugs in inner London. Int J Epidemiol 24, S79-S84.
M. L., Kolb-Bachofen V. (1995). Nitric oxide Morton J. F. (1980): “Caribbean and Latin American
generation during cellular metabolization of the Folk Medicine and its influence in the United States.”
diabetogenic N-methyl-nitroso-urea: Streptozotocin Q. J. Crude Drug Res. 18(2), 57-75.
contributes to islet cell DNA damage. Biol. Chem. Movassat D., Saulnier C. Portha B. (1997): Insulin
Hoppe-Seyler, 376,179–185. administration enhances growth of the β-cell mass in
Liaw C. C. et al. (2002): “New cytotoxic streptozotocin-treated newborn rat. Diabetes 46, 1445-
monotetrahydrofuran annonaceous acetogenins from 1452.
Annona muricata.” J. Nat. Prod. 65(4), 470-475. Nathan D. M., Cleary P. A., Backlund J. Y., Genuth
Liu Y., Terata K., Chai Q., Li H., Kleinman L. H., S. M., Lachin J .M., Orchard T. J., Raskin P.,
Gutterman D. D. (2002): Peroxynitrite inhibits Ca2+- Zinman B. (2005): Diabetes Control and
activated K+ channel activity in smooth muscle of Complications Trial/ Epidemiology Epidemiology of
human coronary arterioles. Circ Res. 91, 1070-1076. Diabetes Interventions and Complications (DCCT
Lorke D. A. (1983): A new approach to practical acute /EDIC) Study Research Group. Intensive diabetes
toxicity testing. Arch Toxicol 54, 275-287. treatment and cardiovascular disease in patients with
Lopez Abraham A. M. (1979): Plant extracts with type 1 diabetes. N Engl J Med, 353, 2643-2653.
cytostatic properties growing in Cuba. I. Rev Cubana Oberlies N. H., et al. (1995): Tumor cell growth
Med Trop 31(2), 97-104. inhibition by several Annonaceous acetogenins in an in
Maritim A. C., Sanfers R. A., Watkins J. B. (2003): vitro disk diffusion assay. Cancer Lett. 96(1), 55-62.
Diabetes, Oxidative stress, and antioxidants: A review. Ohkawa H., Ohishi N., Yagi K. (1979). Assay for
J Biochem Mol Toxicol. 17, 24-38. lipid peroxides in animal tissues by thiobarbituric acid
Marles R. J., Farnsworth N. R. (1995): Antidiabetic reaction. Anal Biochem., 95, 351–358.
plants and their active constituents. Phytomedicine, 2, Ojewole J. A. O. (2001): Traditional medicine and
137-189. African indigenous plant remedies: Evaluation of
Matkovics, B., Kotorman, M., Varga, I. S., Hai, D. crude plant drugs used as antidiabetic remedies in Zulu
Q. and Varga C. (1998). Oxidative stress in folk medicine. Curare, 24, 143-160.
experimental diabetes induced by streptozotocin. Acta Ojewole J. A. O. (2004): Evaluation of the analgesic,
Physiol. Hung., 85: 29–38. anti-inflammatory and antidiabetic properties of
Matsuoka T., Kajimoto Y., Watada H., Kaneto H., Sclerocarya birrea (A. Rich.) Hochst. (Anacardiaceae)
Kishimoto M., Umayahara Y., Fujitani Y., Kamada stem-bark aqueous extract in mice and rats. Phytother
T., Kawamori R., Yamasaki Y. (1998). Glycation- Res, 18, 601-618.
dependent, reactive oxygen species-mediated Ojewole J. A. O. (2005): Antinociceptive, anti-
suppression of the insulin gene promoter activity in inflammatory and antidiabetic effects of Bryophyllum
HIT cells. J. Clin. Invest., 99, 144–150. pinnatum (Crassulaceae) leaf aqueous extract. J.
Merzouk H., Madani S., Chabane D., Prost J., Ethnopharmacol. 99, 13-19.
Bouchenak M., Belleville J. (2000). Time-course of Padma P., et al. (2001): “Effect of Annona muricata
changes in serum glucose, insulin, lipids and tissue and Polyalthia cerasoides on brain neurotransmitters
and enzyme monoamine oxidase following cold Tromo J. R., et al. (2003): In vitro antitumor
immobilization stress.” J. Natural Remedies; 1(2), 144- structure-activity relationships of threo/trans /threo
146. mono-tetrahydro-furanic acetogenins: Correlations
Patlak M. (2002): “New weapons to combat an acient with their inhibition of mitochondrial complex I.
disease: treating diabetes” FASEB J 16(14), 1853. Oncol. Res. 14(3), 147-154.
Ross I. A. (1999): Medicinal plants of the World: Turko I. V., Marconges S. Murad F. (2001):
Chemical Constituents, Traditional and Modern Diabetes-associated nitration of tyrosine and
Medicinal Uses. Humana Press: Totowa, New Jersey, inactivation of succinyl-CoA:3-oxoacid CoA-
pp. 263-272. transferase. Am J Physiol. 281, H2289-2294.
Rossini A. A., Williams R. M., Appel M. C., Like A. Uchigata Y., Yamamoto H., Kawamura A.,
A. (1978). Complete protection from low-dose Okamoto H. (1982): Protection by superoxide
streptozotocin-induced diabetes in mice. Nature, 276, dismutase, catalase and poly (ADP-ribose) sunthetase
182–184. inhibitors against alloxan-and streptozotocin-induced
Schultes R. E., Raffauf A. (1990): The Healing islet DNA strand breaks and against the inhibition of
Forest: Medicinal and toxic plants of the Northwest proinsulin synthesis. J. Biol. Chem., 257, 6084–6088.
Amazonia. Portland: R. F. Dioscorides Press. Vasquez M. R. (1990): Useful plants of Amazonian
Standman E. R., Oliver C. N. (1991): Metal-catalyzed Peru. Second Draft. Filed with USDA’s National
oxidation of proteins. Physiological consequences. J. Agricultural Library. USA.
Biol. Chem. 266, 2005-2008. Weniger B. et al. (1986): Popular medicine of the
Starke-Reed P. E., Oliver C. N. (1989): Protein Central Plateau of Haiti. 2. Ethnopharmacological
oxidation and proteolysis during aging and oxidative Inventory J Ethnopharmacol 171, 13-30.
stress. Arch. Biochem. Biophys. 275, 559-567. Weiss R. B. (1982). Streptozotocin: a review of it
Stevens A. (1982): The haematoxylins. In: Bancroft pharmacology, efficacy and toxicity. Cancer Treat.
JD, Stevens A, eds. Theory and practice of Rep., 66, 427–438.
Histological Techniques. London: Longman Group; World Health Organization. (2000): Obesity:
pp., 109-122. Preventing and managing the global
Sundarrao K. (1993): Preliminary Screening of epidemic. Geneva: WHO Technical Report Series, No
antibacterial and antitumor activities of Papua Guinean 894.
Native Medicinal Plants. Int J Pharmacology 311,3-6. World Health Organization. (1999): Definition,
Taniyama Y., Griendling K. K. (2003): Reactive Diagnosis and Classification of Diabetes mellitus and
oxygen species in the vasculature: Molecular and its Complications: Part I: diagnosis and classification
cellular mechanisms. Hypertension. 42, 1075-1081. of diabetes. Geneva WHO/NCD/NCS 99(2), pp. 1-58.
Tape A. L. (1975): Lipid peroxidation and fluorescent Yuan S. S., et al. (2003): Annonacin, a mono-
molecular damage to membranes. In: Pathology of Cell tetrahydrofuran acetogenin, arrest cancer cells at the
Membranes, edited by B. F. Trump and A. U. Arstila. G1 phase and causes cytotoxicity in a Bax- and
New York: Academic, pp. 145-170. caspase-3-related pathway. Life Sci. 72(25), 2853-
Tappel A. L. (1978). Glutathione peroxidase and 2861
hydroperoxides. Methods Enzymol., 52, 506–513.
Tiedge M., Lortz S., Drinkgern J., Lenzen S. (1997).
Relation between antioxidant enzyme gene
_expression and antioxidative defense status of insulin-
producing cells. Diabetes; 46, 1733-1742.